H.R. 2319119th CongressPassed one chamberLatest action Apr 22, 2026Decoded by AI · checked against the record
Official title: Women and Lung Cancer Research and Preventive Services Act of 2025
Introduced:
Read the official bill on Congress.govThe plain-language version leads. The official text is always the reference.
HR 2319 requires HHS to review lung cancer research on women and underserved groups and report to Congress within two years.
40-second read · 4 questions answered below
HR 2319 directs HHS, working with the Defense Department and Veterans Affairs, to review existing lung cancer research related to women and underserved populations, identify knowledge gaps, and explore opportunities for new studies. It also asks HHS to consider a national screening strategy and a public awareness campaign. The bill requires only a study and report, not new programs or direct treatment funding.
Government health agencies and researchers at HHS, the Defense Department, and Veterans Affairs would conduct the review. Women, veterans, and underserved populations such as low-income or rural communities could be indirectly affected by future findings.
The review could inform future screening guidelines, research funding, or awareness campaigns, but the bill itself creates no immediate changes to care or policy.
AI-drafted summary. Verify it against the official text before you act on it. Read the official bill on Congress.gov
Right now: it passed the House, and the official record shows nothing new since. If the Senate changes it, it goes back to the House before reaching the President.
Latest action: — Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 380.